The most obvious place Adamantem should be able to get earnings growth is from getting Celemetrix back on track, but there are good tailwinds across all their divisions. I'd be very surprised if the business didn't generate EBITDA of at least $18m in FY20 and closer to $20m in the FY21 without any further acquisitive augmentation.
The market really screwed the pooch on this one, misreading the excellent platform for growth that had been created and the excellent operating environment unfolding - Eternalgrowth
Add to My Watchlist
What is My Watchlist?